Fig. 4: SS-OCTA 6 × 6 mm scans of a growing MNV that developed exudation after 11 months with 28-month follow-up visits. | Eye

Fig. 4: SS-OCTA 6 × 6 mm scans of a growing MNV that developed exudation after 11 months with 28-month follow-up visits.

From: Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity

Fig. 4

A SS OCTA photograph shows a 2.544 mm2 treatment-naïve nonexudative MNV lesion in the patient’s left eye at baseline. B SS OCTA shows that the area of subclinical MNV lesion increases to 4.007 mm2 in eleven months and develops exudation. C SS OCTA shows the area of nonexudative MNV lesion as 3.767 mm2 before the first intravitreal anti-VEGF treatment and D the lesion shrinks to 1.961 mm2 two weeks after anti-VEGF treatment. E SS OCTA shows that the area of subclinical MNV lesion re-enlarges to 4.273 mm2, and F to 4.298 mm2 eight and nine months after the anti-VEGF treatment, respectively.

Back to article page